Oxygenta Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE102E01018
  • NSEID:
  • BSEID: 524636
INR
49.85
0.28 (0.56%)
BSENSE

Jun 03, 03:30 PM

BSE+NSE Vol: 6.22 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 798135,
    "name": "Oxygenta Pharma",
    "stock_name": "Oxygenta Pharma",
    "full_name": "Oxygenta Pharmaceutical Ltd",
    "name_url": "stocks-analysis/oxygenta-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "49.85",
    "chg": 0.28,
    "chgp": "0.56%",
    "dir": 1,
    "prev_price": "49.57",
    "mcapval": "183.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524636,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE102E01018",
    "curr_date": "Jun 03, 03:30 PM",
    "curr_time": "05:33 AM",
    "last_traded_at": "Jun 03, 03:30 PM IST",
    "bse_nse_vol": "6.22 k",
    "exc_status": "Active",
    "traded_date": "Jun 03, 2026",
    "traded_date_str": "2026 06 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/oxygenta-pharma-798135-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Oxygenta Pharmaceutical Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharmaceutical-ltd-is-rated-strong-sell-4024355",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/OxygentaPharmac_mojoScore_4024355.png",
        "date": "2026-05-31 10:10:18",
        "description": "Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 31 May 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "When is the next results date for Oxygenta Pharmaceutical Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-oxygenta-pharmaceutical-ltd-4001749",
        "imagepath": "",
        "date": "2026-05-20 23:19:01",
        "description": "The next results date for Oxygenta Pharmaceutical Ltd is scheduled for 23 May 2026...."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharmaceutical-ltd-is-rated-strong-sell-3998872",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/OxygentaPharmac_mojoScore_3998872.png",
        "date": "2026-05-19 10:10:22",
        "description": "Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 19 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharmaceutical-ltd-is-rated-strong-sell-3981512",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/OxygentaPharmac_mojoScore_3981512.png",
        "date": "2026-05-08 10:10:22",
        "description": "Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharmaceutical-ltd-is-rated-strong-sell-3964278",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/OxygentaPharmac_mojoScore_3964278.png",
        "date": "2026-04-27 10:10:25",
        "description": "Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 27 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharmaceutical-ltd-is-rated-strong-sell-3949152",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/OxygentaPharmac_mojoScore_3949152.png",
        "date": "2026-04-16 10:10:16",
        "description": "Oxygenta Pharmaceutical Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharmaceutical-ltd-is-rated-strong-sell-3933253",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/OxygentaPharmac_mojoScore_3933253.png",
        "date": "2026-04-05 10:10:11",
        "description": "Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 05 April 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Markets Rally, But Oxygenta Pharmaceutical Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-falls-to-52-week-low-of-rs453-3928529",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/OxygentaPharmac_priceRelatedfactors_3928529.png",
        "date": "2026-04-01 09:59:54",
        "description": ""
      },
      {
        "title": "Markets Rally, But Oxygenta Pharmaceutical Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3924463",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/OxygentaPharmac_priceRelatedfactors_3924463.png",
        "date": "2026-03-30 11:19:08",
        "description": ""
      }
    ],
    "total": 231,
    "sid": "798135",
    "stock_news_url": "https://www.marketsmojo.com/news/oxygenta-pharmaceutical-798135"
  },
  "announcements": [
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "26-May-2026",
      "details": "Annual Secretarial Compliance Report for the year ended 31.03.2026 pursuant to Regulation 24A of SEBI (LODR) Regulations 2018.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On 23Rd May 2026",
      "datetime": "23-May-2026",
      "details": "Outcome of the Board meeting held on 23rd May 2026.",
      "source": "BSE"
    },
    {
      "caption": "Audited Financial Results For The Quarter And Year Ended 31.03.2026.",
      "datetime": "23-May-2026",
      "details": "Audited Financial Results for the Quarter and Year ended 31.03.2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Compliances-Reg.24(A)-Annual Secretarial Compliance

26-May-2026 | Source : BSE

Annual Secretarial Compliance Report for the year ended 31.03.2026 pursuant to Regulation 24A of SEBI (LODR) Regulations 2018.

Board Meeting Outcome for Outcome Of The Board Meeting Held On 23Rd May 2026

23-May-2026 | Source : BSE

Outcome of the Board meeting held on 23rd May 2026.

Audited Financial Results For The Quarter And Year Ended 31.03.2026.

23-May-2026 | Source : BSE

Audited Financial Results for the Quarter and Year ended 31.03.2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available